Skip to main content

Table 2 Residence times (MBq-h/MBq) of [177 Lu]Lu-DOTAZOL in comparison with [177Lu]Lu-EDTMP [5]

From: Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results

Organs

[177Lu]Lu-DOTAZOL

[177Lu]Lu-EDTMP [5]

PT1

PT2

PT3

PT4

Mean

± SD

Kidneys

0.96

2.01

2.43

1.96

1.84

0.63

 

Trabecular bone

27.45

34.95

33.45

31.85

31.93

3.24

48.62

Cortical bone

27.45

34.95

33.45

31.85

31.93

3.24

48.62

Red marrow

0.01

0.03

0.04

0.03

0.03

0.01

0.07

Urinary bladder contents

1.59

1.48

1.51

1.50

1.52

0.05

7.23

Remainder of body

0.23

44.06

0.93

1.40

11.65

21.61

27.37

Whole body

56.10

116.00

70.30

67.10

77.38

26.46

131.91

Blood

0.19

0.34

0.35

0.46

0.34

0.11

0.98